US Stocks
SYRS
Syros Pharmaceuticals, Inc. Common Stock
$0.0000
+0.0000 (+0.00%)
Volume:
0 ($0.00)
Market Capitalization:
-
Syros Pharmaceuticals Price Chart
*There is no price data available for this ticker
Syros Pharmaceuticals Volume Chart
*There is no volume data available for this ticker
Syros Pharmaceuticals Market Segments
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
*No Trades in Segment
Premarket Yesterday
*No Trades in Segment
Syros Pharmaceuticals News
There is no current news for this stock at the moment.
Syros Pharmaceuticals Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Syros Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $0.0002 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.0002 |
| 20 Day Moving Average (SMA20) | $0.0002 |
| 50 Day Moving Average (SMA50) | $0.0003 |
| 100 Day Moving Average (SMA100) | $0.0003 |
| 200 Day Moving Average (SMA200) | $0.0009 |
Syros Pharmaceuticals Statistics
| Average Volume (30 Days) | 17.25K |
|---|---|
| P/E Ratio (Current) | .00 |
| EPS (Current) | -$3.65 |
| Dividend Yield | — |
| Free Cash Flow | -$100.05M |
| Cash Ratio | 2.05 |
| Current Ratio | 2.25 |
| Quick Ratio | 2.25 |
| Debt to Equity | -3.69 |
| Enterprise Value | -$17.19M |
| EV to EBITDA | 0.16 |
| EV to Sales | -44.54 |
| Price to Book | 0.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 0.00 |
| Return on Assets | -1.15% |
| Return on Equity | 8.79% |
Syros Pharmaceuticals Stock Splits
There has been 1 stock split for Syros Pharmaceuticals (SYRS). The reverse stock split occured on September 19, 2022 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 19, 2022 | Reverse | 10:1 |
Syros Pharmaceuticals Dividends
There have been no dividends for Syros Pharmaceuticals (SYRS).